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STUDY QUESTION: Does ART impact the secondary sex ratio (SSR) when compared to natural conception?
SUMMARY ANSWER: IVF and ICSI as well as the stage of embryo transfer does impact the overall SSR.
WHAT IS KNOWN ALREADY: The World Health Organization quotes SSR for natural conception to range between 103 and 110 males
per 100 female births.
STUDY DESIGN, SIZE, DURATION: A total of 1 376 454 ART cycles were identified, of which 1 002 698 (72.8%) cycles involved IVF or
ICSI. Of these, 863 859 (85.2%) were fresh cycles and 124 654 (12.4%) were frozen cycles. Missing data were identified in 14 185 (1.4%) cycles.
PARTICIPANTS/MATERIALS, SETTING, METHODS: All cycles recorded in the anonymized UK Human Fertilisation and Embryology
Authority (HFEA) registry database between 1991 and 2016 were analysed. All singleton live births were included, and multiple births were
excluded to avoid duplication.
MAIN RESULTS AND THE ROLE OF CHANCE: The overall live birth rate per cycle for all IVF and ICSI treatments was 26.2%
(n =262 961), and the singleton live birth rate per cycle was 17.1% (n =171 399). The overall SSR for this study was 104.0 males per 100
female births (binomial exact 95% CI: 103.1–105.0) for all IVF and ICSI cycles performed in the UK recorded through the HFEA. This was
comparable to the overall SSR for England andWales at 105.3 males per 100 female births (95% CI: 105.2–105.4) from 1991 to 2016 obtained
from the Office of National Statistics database. Male predominance was seen with conventional insemination in fresh IVF treatment cycles (SSR
110.0 males per 100 female births; 95% CI: 108.6–111.5) when compared to micro-injection in fresh ICSI treatment cycles (SSR 97.8 males per
100 female births; 95% CI: 96.5–99.2; odds ratio (OR) 1.16, 95% CI 1.12–1.19, P < 0.0001), as well as with blastocyst stage embryo transfers
(SSR 104.8 males per 100 female births; 95% CI: 103.5–106.2) when compared to a cleavage stage embryo transfer (SSR 101.2 males per 100
female births; 95% CI: 99.3–103.1; OR 1.03, 95% CI 1.01–1.06, P =0.011) for all fertilization methods.
LIMITATIONS, REASONS FOR CAUTION: The quality of the data relies on the reporting system. Furthermore, success rates through
ART have improved since 1991, with an increased number of blastocyst stage embryo transfers.
WIDER IMPLICATIONS OF THE FINDINGS: This is the largest study to date evaluating the impact of ART on SSR. The results
demonstrate that, overall, ART does have an impact on the SSR when assessed according to the method of fertilization (ICSI increased female
births while IVF increased males). However, given the ratio of IVF to ICSI cycles at present with 60% of cycles from IVF and 40% from ICSI,
the overall SSR for ART closely reflects the population SSR for, largely, natural conceptions in England and Wales.
STUDY FUNDING/COMPETING INTEREST(S): The study received no funding. C.M.B. is a member of the independent data monitoring
group for a clinical endometriosis trial by ObsEva. He is on the scientific advisory board for Myovant and medical advisory board for Flo Health.
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WHAT DOES THIS MEAN FOR PATIENTS?
IVF was first developed over 40 years ago. More than 250 000 babies have since been born as a result of treatment within the UK. The gender
(male or female) of the child at birth is referred to as secondary sex ratio (SSR). This ratio is expressed as the number of males per 100 females
at birth. The overall SSR with natural conception ranges between 103 and 110 males per 100 female births.
TheHuman Fertilisation and Embryology Authority (HFEA) regulates fertility treatment within theUK. This study looks at all fertility treatments
leading to a live birth recorded on the HFEA database between 1991–2016. A total of 1 376 454 treatment cycles were undertaken during this
time. The total number of live births has then been categorized by the sex of the child at birth and the type of treatment technique employed.
The number of female births was found to be greater than the number of male births with certain techniques, including ICSI involving the
injection of sperm into each individual egg (97.8 males per 100 female births) and with the transfer of day 2–3 stage embryos, referred to as
cleavage stage embryos (101.2 males per 100 female births). In contrast, an increased number of male births was seen with IVF treatments,
involving the placement all collected eggs in a dish with the sperm and awaiting fertilization (110.0 males per 100 female births), and with the
transfer of day 5–6 stage embryos, referred to as blastocyst stage embryos (104.8 males per 100 female births).
This is the largest study to date looking at SSR and confirms earlier suggestions of a shift in the gender balance with certain treatment
types, whereby IVF treatment is shown to increase the SSR and ICSI treatment decrease the SSR, when compared to natural conception.
Overall, however, the SSR for all techniques is maintained at 104.0 males per 100 female births, similar to that of natural conception, due to
the current ratio of IVF to ICSI treatments. Furthermore, a shift in favour of either treatment type (IVF or ICSI) could lead to an alteration in
the SSR.
Introduction
IVF was first developed over 40 years ago. More than 250 000 babies
have since been born as a result of assisted reproductive treatment
(ART) within the UK and millions more worldwide (HFEA, November
2016). The human sex ratio is often divided into primary (PSR) and
secondary sex ratio (SSR), where the PSR refers to gender after fertil-
ization and the SSR refers to gender at birth. A discrepancy between
these two parameters can be the result of spontaneous miscarriages
or terminations. These ratios are often expressed as the proportion of
males or the number of males per 100 female births (Jacobsen et al.,
1999). Overall, the PSR is estimated to range between 107 and 170
males per 100 female births (Pergament et al., 2002), while the overall
SSR is 106 males per 100 female births (Grech et al., 2002). The SSR
for England and Wales (Fig. 1) has ranged between 103 and 107 males
per 100 female births for the years 1838–2014 (Ghosh, 2019).
Previous studies have alluded to various factors that could potentially
lower the SSR, such as maternal age (Rueness et al., 2012), external
stressors such as war (Macmahon and Pugh, 1954), selective fetocide
that predominates in certain ethnicities (Seth, 2007) and environmental
influences in the form of pollution (Terrell et al., 2011). While most
of these discussions have been based on natural conception, recent
evidence suggests that ART can also alter the SSR. A study by Dean
et al. (2010) involving fertility clinics in Australia and New Zealand
evaluated the SSR from babies born following a single embryo transfer.
They demonstrated a reduction in the SSR when comparing the differ-
ent fertilization methodologies of ICSI with IVF (Dean et al., 2010).
Furthermore, a sub-analysis of this data highlighted that the day of
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transfer (i.e. the stage of embryonic development during an ART cycle)
also had an impact on the SSR, with a higher proportion of male births
reported following a blastocyst stage transfer when compared with
the transfer of a cleavage stage embryo, and this was found to be
independent of the method of fertilization (Dean et al., 2010).
Improvements in embryo culture media and advances with time-
lapse technology have further improved the overall pregnancy rates.
A retrospective, single-centre study looking at 4411 singletons born
following ART demonstrated no impact on the SSR of the various
culture media available with IVF treatment but did show an increase
in male births with ICSI in certain culture media (Zhu et al., 2015).
However, the current evidence is conflicting with other studies
demonstrating no association between ART and SSR, but they are
limited by their small sample sizes (Altman and Bland, 1995; Luke et al.,
2009; Al-Jaroudi et al., 2018). This is further reflected in studies looking
at semen parameters and SSR, with even fewer patients included (Bae
et al., 2017; Malo et al., 2017).
The inclusion of multiple births presents a compounding factor,
further complicating the calculation of SSR, given that the weighting
of a particular sex is dependent on the type of twin (monozygotic
versus dizygotic). The increasing success rates of ART, partially
attributed to extended embryo culture (Glujovsky et al., 2012)
and improved morphological assessment of the embryo (Harton
et al., 2013), increase the importance of being able to evaluate
its long-term impact on society through an evaluation of gender
equilibrium.
This study aims to address the imbalance of SSR in assisted repro-
duction. Using the wealth of the Human Fertilisation and Embryology
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Figure 1 The SSR for England and Wales as produced by the Office of National Statistics from 1838–2016.The secondary sex ratio
(SSR) on the y-axis denotes the number of males per 100 female births.
Authority (HFEA) database, this report represents the largest registry-
based study involving SSR to date.
Methods
A retrospective study was carried out using the HFEA anonymized reg-
istry database analysing all singleton live births following ART between
1991 and 2016. The criteria for excluding cycles from this study
were the use of IUI, IVF plus gamete intrafallopian transfer (GIFT)
or IVF plus zygote intrafallopian transfer (ZIFT) and multiple preg-
nancies defined as more than one live birth per woman in the same
pregnancy.
All UK-based licensed fertility centres are required by law to report
their auditable data to the HFEA. Data from the Office of National
Statistics (ONS) was obtained for all live birth SSR in England and
Wales including natural and ART conceptions between 1838 and 2016
(Ghosh, 2019).
The results have been analysed in relation to maternal age (age
ranges 18–34, 35–37, 38–39, 40–42, 43–44 and 45–50 years, arranged
as categorical variables as per the HFEA data set, using 18–34 years
as the reference category), mode of fertilization (IVF and ICSI) and
stage of transfer (cleavage stage and blastocyst stage), adjusting for
type of fresh treatment cycle (IVF versus ICSI), maternal age and stage
of transfer.
Statistical analysis
The proportion of males was calculated with the associated exact 95%
binomial CI and the SSR presented as the proportion of males per
100 female births. The data were stratified by categorical variables
(female age,method of fertilization, type of cycle and stage of transfer).
Binary logistic regression was conducted on the association between
SSR (outcome) and each of the covariates (female age, method of
fertilization and stage of transfer). Furthermore, a multivariable logistic
regression was used to adjust for potential confounding variables
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(female age,method of fertilization and stage of transfer). AChi-square
test for association was used to compare the method of fertilization
and stage of transfer. Statistical analysis was conducted using the SPSS
Statistics version 22.0 (IBM, UK). A P-value of <0.05 was considered
statistically significant.
Results
A total of 1 376 454ART cycleswere identified, of which 1 002 698 cycles
incorporated IVF or ICSI (excluding cycles involving GIFT, ZIFT and
IUI). Of these cycles, 863 859 (85.15%) were fresh cycles: IVF was the
method of insemination in 517 402 (59.89%), and ICSI was utilized
in 346 457 (40.11%) cycles. Frozen cycles accounted for 124 654
(12.43%) treatment cycles; IVF was the method of insemination in
80 995 (64.98%) and ICSI was utilized in 43 659 (35.02%) cycles.
Incomplete data was identified in 14 185 (1.41%) cycles, which were
excluded from the analysis.
The baseline characteristics of the included treatment cycles are
described in Table I.
The overall live birth rate per included cyclewas 26.2% (n=262 961),
and the singleton live birth rate per cycle was 17.1% (n =171 399).
The overall SSR for this study was 104.0 males per 100 female births
(Binomial Exact 95% CI: 103.1–105.0). This was comparable to the
overall SSR for all births in England and Wales at 105.3 males per
100 female births (95% CI: 105.2–105.4), including those conceived
through ART, which accounted for ∼1% of all births for the study
duration (Fig. 2).
Overall, the female age was not shown to be significantly asso-
ciated with the SSR. The SSR was found to be significantly different
from the reference category (age 18–34 years) only for women aged
35–37 years (n=41 197 singleton live births), with a SSR of 102.6males
per 100 female births (95% CI: 100.6–104.6; odds ratio (OR) 0.96,
95% CI 0.94–0.99, p = 0.025), compared to the reference category
18–34 years (Tables II and III). However, it was not possible to draw
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Table I Distribution of IVF and ICSI cycles according to female age groups, method of fertilization, type of treatment
cycle, stage of embryo transfer and male subfertility and the corresponding live birth rate per category.
Variables Total IVF and ICSI Cycle (n) (%) Singleton Live Birth (n) (%) IVF Cycle (n) (%) ICSI Cycle (n) (%)
......................................................................................................................................................................................
Age (years)
18–34 452751 (45.7%) 90391 (20.0%) 264353 (45.1%) 188398 (46.6%)
35–37 230629 (23.3%) 41197 (17.9%) 137700 (23.5%) 92929 (23.0%)
38–39 138177 (13.9%) 19876 (14.4%) 82586 (14.1%) 55591 (13.8%)
40–42 118701 (12.0%) 12167 (10.3%) 70927 (12.1%) 47774 (11.8%)
43–44 32738 (3.3%) 2454 (7.5%) 19935 (3.4%) 12803 (3.2%)
45–50 18037 (1.8%) 2096 (11.6%) 11278 (1.9%) 6759 (1.7%)
Type of cycle
Fresh 863859 (87.4%) 149544 (17.3%) 517402 (86.5%) 346457 (88.8%)
Frozen 124654 (12.6%) 17434 (14.0%) 80995 (13.5%) 43659 (11.2%)
Stage of Transfer
Cleavage 221635 (35.8%) 43467 (19.6%) 105213 (35.6%) 116422 (35.9%)
Blastocyst 398078 (64.2%) 95011 (23.9%) 190084 (64.4%) 207994 (64.1%)
Male Subfertility
Yes 448444 (44.7%) 76565 (17.1%) 185352(31.0%) 263093 (65.1%)
No 554254 (55.3%) 91616 (16.5%) 413045 (69.0%) 141209 (34.9%)
Figure 2 SSR for all births in England and Wales from 1991 to 2016 from the HFEA dataset and Office of National Statistics.
any further correlation based on the impact of female age on SSR, apart
from this observed single variation.
Conventional IVF treatment cycles favoured male singleton live
births, 110.0 males per 100 female births (95% CI: 108.6–111.5)
when compared to ICSI, 97.8 males per 100 female births (95% CI:
96.5–99.2); OR 1.16, 95% CI 1.12–1.19, P < 0.0001 (Tables II and III).
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A further sub-analysis showed that the SSR was not influenced by the
type of cycle (fresh or frozen) (OR 0.99, 95% CI 0.93–1.05, P =0.708).
Univariate analysis of the impact of the method of fertilization in
frozen treatment cycles on the SSR demonstrated 107.6 males per
100 female births (95% CI: 103.5–111.8) in frozen IVF treatment cycles
and 96.3 males per 100 female births (95% CI: 91.9–100.9) in frozen
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Table II Distribution of male offspring as a percentage and SSR according to female age groups, fertilization method, type
of treatment cycle, stage of embryo transfer and male subfertility from the HFEA data set and comparative population
data from the ONS.
Variables Singleton
Live Birth
Male Offspring
(n)
Male Offspring
(%)
Binomial Exact
95% CI
SSR∗ Binomial Exact
95% CI
.......................................................................................................................................................................................
Age (years)
18–34 90391 46305 51.2% 50.9–51.6 105.0 103.7–106.4
35–37 41197 20862 50.6% 50.2–51.1 102.6 100.6–104.6
38–39 19876 10081 50.7% 50.0–51.4 102.9 100.0–105.8
40–42 12167 6201 51.0% 50.1–51.9 103.9 100.0–105.8
43–44 2454 1219 49.7% 47.7–51.7 98.7 91.2–106.8
45–50 2096 1089 52.0% 49.8–54.1 108.1 99.3–117.8
Method of Fertilisation
IVF 88291 46255 52.4% 52.1–52.7 110.0 108.6–111.5
ICSI 79890 39502 49.5% 49.1–49.8 97.8 96.5–99.2
Type of Cycle
Fresh 149544 76299 51.0% 50.8–51.3 104.2 103.1–105.2
Frozen 17434 8840 50.7% 50.0–51.5 102.9 99.9–106.0
Frozen
IVF 10368 5374 51.8% 50.8–52.8 107.6 103.5–111.8
ICSI 7066 3466 49.1% 47.9–50.2 96.3 91.9–100.9
Stage of Transfer
Cleavage 43467 21861 50.3% 49.8–50.8 101.2 99.3–103.1
Blastocyst 95011 48629 51.1% 50.9–51.5 104.8 103.5–106.2
IVF Transfers
Cleavage 20302 10536 51.9% 51.2–52.6 107.9 105.0–110.9
Blastocyst 44606 23579 52.9% 52.4–53.3 112.1 110.1–114.2
ICSI Transfers
Cleavage 23165 11325 48.9% 48.2–49.5 95.7 93.2–98.2
Blastocyst 50405 25050 49.7% 49.3–50.1 98.8 97.1–100.5
Male Subfertility
Yes 76565 38613 50.4% 50.1–50.8 101.7 100.3–103.2
No 91616 47144 51.5% 51.1–51.8 106.0 104.6–107.4
Database Outcomes
ONS Population 17,366,972 8905999 51.2 51.3–51.3 105.3 105.2–105.4
HFEA IVF+ ICSI 168181 85757 51.0 50.8–51.2 104.0 103.1–105.0
HFEA IVF only 88291 46255 52.4 52.1–52.7 110.0 108.6–111.5
HFEA ICSI only 79890 39502 49.5 49.1–49.8 97.8 96.5–99.2
∗SSR—Secondary sex ratio defined as the number of male live births per 100 female live births.
HFEA: Human Fertilisation and Embryology Authority, ONS: Office of National Statistics
ICSI treatment cycles; OR 1.12, 95% CI 1.05–1.19, P < 0.0001. These
findings are maintained when adjusted for stage of transfer and female
age (OR 1.16, 95% CI 1.04–1.29, P =0.010).
A clear predominance in favour of male births is seen with
blastocyst stage embryo transfers, with an SSR of 104.8 males per
100 female births (95% CI: 103.5–106.2), in comparison to cleavage
stage embryo transfers, with an SSR of 101.2 males per 100 female
births (95% CI: 99.3–103.1); OR 1.03, 95% CI 1.01–1.06, p = 0.011
(Table II).
A further subgroup analysis for the method of fertilization main-
tained this trend, with blastocyst stage transfers resulting from both
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conventional IVF and ICSI treatment cycles favouring male births when
compared to cleavage stage transfers (adjustedOR (aOR) 1.03, 95%CI
1.01–1.06, P=0.011) (Table III). The SSR for a blastocyst stage embryo
transfer resulting from conventional insemination in an IVF treatment
cycle was 112.1 males per 100 female births (95% CI: 110.1–114.2;
OR 1.04, 95% CI 1.00–1.08, P =0.033) and 98.8 males per 100 female
births (95% CI: 97.1–100.5; OR 1.03, 95% CI 1.00–1.06, P =0.050)
from ICSI treatment cycles, when compared to cleavage stage embryo
transfers.
A total of 448 444 cycles were performed for male factor subfertility,
of which 185 352 (41.3%) involved conventional IVF treatment cycles
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Table III Binary logistic regression for prediction of a male birth, including the variables female age group, method of
fertilization, type of treatment cycle, stage of embryo transfer and male subfertility.
Variables Singleton
Live Birth
Male Offspring
(n)
SSR∗ OR∗∗ (male)
(95% CI)
P-value aOR∗∗a (male)
(95% CI)
P-value
.....................................................................................................................................................................................
Age (years)
18–34 90391 46305 105.0 1 1
35–37 41197 20862 102.6 0.98 (0.95−1.00) 0.05 0.96 (0.94–0.99) 0.025
38–39 19876 10081 102.9 0.98 (0.95–1.01) 0.195 0.98 (0.93–1.01) 0.108
40–42 12167 6201 103.9 0.99 (0.95–1.03) 0.588 1.00 (0.95–1.05) 0.934
43–44 2454 1219 98.7 0.94 (0.87–1.02) 0.129 0.97 (0.86–1.08) 0.531
45–50 2096 1089 108.1 1.03 (0.94–1.12) 0.509 0.94 (0.82–1.07) 0.32
Method of Fertilisation
IVF 88291 46255 110.0 1.13 (1.10–1.15) <0.0001 1.16 (1.12–1.19) <0.0001
ICSI 79890 39502 97.8 1 1
Type of Cycle
Fresh 149544 76299 104.2 1 1
Frozen 17434 8840 102.9 0.99 (0.96–1.02) 0.430 0.99 (0.93–1.05) 0.708
Frozen
IVF 10368 5374 107.6 1.12 (1.05–1.19) <0.0001 1.16 (1.04–1.29) 0.010
ICSI 7066 3466 96.3 1 1
Stage of Transfer
Cleavage 43467 21861 101.2 1 1
Blastocyst 95011 48629 104.8 1.04 (1.01–1.06) 0.002 1.03 (1.01–1.06) 0.011
IVF Transfers
Cleavage 20302 10536 107.9 1 1
Blastocyst 44606 23579 112.1 1.04 (1.01–1.08) 0.023 1.04 (1.00–1.08) 0.033
ICSI Transfers
Cleavage 23165 11325 95.7 1 1
Blastocyst 50405 25050 98.8 1.03 (1.00–1.07) 0.041 1.03 (1.00–1.06) 0.050
Male Subfertility
Yes 76565 38613 101.7 0.96 (0.94–0.98) <0.0001 1.03 (1.00–1.05) 0.05
No 91616 47144 106.0 1 1
∗SSR – Secondary sex ratio defined as the number of male live births per 100 female live births.
∗∗Binary logistic regression analysis with odds ratio (OR) and 95% CI for male births by a single factor. 1 denotes the reference category.
∗∗aAnalysis adjusted for female age, method of fertilisation and stage of transfer.
and 263 092 (58.7%) ICSI treatment cycles. The singleton live birth rate
for this group was 17.1% (n =76 565). The SSR was lower for patients
with male factor subfertility, at 101.7 males per 100 female births
(95% CI: 100.3–103.2), compared to patients without male factor
subfertility, at 106.0 males per 100 female births (95% CI: 104.6–
107.4) (Table II) (OR 0.96, 95% CI 0.94–0.98, P < 0.0001) (Table III),
suggesting an overall lower odds of a male birth in the presence of
male factor subfertility. However, this trend was not maintained when
adjusted for confounders (aOR 1.03, 95% CI 1.00–1.05, P =0.05)
(Table III), stage of transfer and method of fertilization.
Discussion
This is the largest retrospective registry-based study to date, includ-
ing data from the anonymized HFEA database spanning 1991–2016,
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demonstrating alterations in the SSR with certain ART methodologies
(Fig. 2). The effect of method of fertilization and stage of embryo
transfer on the SSR was found to be statistically significant after adjust-
ing for female age, method of fertilization and stage of transfer, thus
demonstrating an independent effect of these variables on SSR.
The overall UK birth gender ratio currently stands at 105.3 males
per 100 female births (95% CI: 105.2–105.4) and is considered
to lie within the normal boundaries for other countries, with just
over half of all infants born being male (Department of Health,
2013). A study conducted using the HFEA database and the
Scottish Morbidity Record compared ART populations with naturally
conceived children; the authors reported a similar SSR between
the two groups at 103.7 and 103.4 males per 100 female births,
respectively, suggesting no change in the SSR as a result of ART.
However, a subset analysis demonstrated a lower SSR with ICSI
treatment cycles, similar to the findings from this study, but they
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did not reach statistical significance due to the smaller sample size
(Hann et al., 2018).
A number of factors have been suggested to reduce the SSR world-
wide (Luke et al., 2009), both biological (older age of both parents
and higher maternal weight) (Nicolich et al., 2000; Jacobsen, 2001)
and environmental (war, earthquakes, economic distress, sex-selective
termination of pregnancies, discrimination in care practices for girls
[Hesketh and Xing, 2006] and toxins [smoking, pollutants, and pesti-
cides] [Chen et al., 2017]). Furthermore, during normal human devel-
opment there is a trend towards sex-biased mortality, with an overall
greater mortality of female foetuses during pregnancy, postulated to be
secondary to disrupted expression of maternally inherited mRNA or
of RNA synthesized by the embryo (Guo et al., 2017). Another theory
is that the paternal X chromosome retards development to such an
extent that it increases the female mortality rate (Orzacka et al., 2015).
Overall, IVF cycles resulted in a 16% increase in male births
compared to ICSI cycles. This impact on the SSR persisted when
analysed for the transfer of fresh or frozen embryos, with a 13%
and 16% increase seen in male births from fresh and frozen IVF
cycles, respectively, compared to ICSI treatment cycles. This suggests
a greater influence of the method of fertilization (conventional IVF
versus ICSI) on the SSR than the type of cycle (fresh or frozen) being
undertaken.
The potential impact of ICSI on the SSR has been previously
reported, leading to several hypotheses of the underlying mechanism
(Graffelman et al., 1999; Lobel et al., 1993). One such theory is that of
potential mechanical injury to the replication apparatus during micro-
injection of sperm into the oocyte. It has been suggested that by
transecting the zona pellucida, its functional capacity can potentially
be impaired by the introduction of foreign substances into the oocyte
along with an alteration to the natural selection processes (Yu et al.,
2011; Verpoest & Tournaye, 2006). This hypothesis is supported by
our finding of a lower SSR in the ICSI treatment group compared to
the IVF group, as well as to the natural conception group from the
ONS data (Fig. 2).
Furthermore, ICSI is thought to overcome the reduced binding ability
of Y-bearing sperm to oocytes during the physiological fertilization
process (Luke et al., 2009), thus potentially fertilizing an oocyte with
an abnormal Y-bearing sperm. It is important to bear in mind that Luke
et al. (2009) demonstrated a 14% reduction in male births with ICSI
in the absence of male factor subfertility, suggesting that an abnormal
Y-chromosome may not be solely responsible for the differences seen
in the SSR (Luke et al., 2009).
In contrast to the findings in this study, whereby amale predominance
is seen with blastocyst stage embryo transfers whether the method of
fertilization is IVF or ICSI, Lee et al. (2016) demonstrated no difference
in the SSR in euploid embryos reaching the blastocyst stage of develop-
ment, determined by a complete analysis of the chromosomes through
pre-implantation genetic screening (Lee et al., 2016).
Blastocyst stage embryo transfers have been speculated to lead to
a male predominance, secondary to their quicker growth potential
due to their ability to uptake pyruvate and glucose at a higher rate
compared to female embryos, thus achieving the blastocyst stage of
development faster than female embryos (Pergament et al., 1994; Ray
et al., 1995). Furthermore, male and female human embryos have
different survival rates in the early stages of embryogenesis with a
significantly higher primary sex ratio compared to the SSR, suggesting
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a poorer survival rate for male embryos overall (Luke et al., 2009).
Consideration should therefore be given to the development of time-
lapse technology, developed to promote improved embryo selection
at an earlier stage, which may inadvertently push the SSR in favour of
female births while trying to avoid the impact of possible epigenetic
changes with prolonged culture. Data on time-lapse technology were
not available from the HFEA cohort, and therefore, this theory could
not be further explored.
Earlier reports have suggested no association of the underlying cause
of subfertility with the SSR (Dean et al., 2010). In the present study,
a sub-analysis showed a statistically significant variation in the SSR in
the presence of male factor subfertility, with a 4% decrease in male
births when compared to the cohort without male factor subfertility;
however, this effect is not present after adjusting for potential con-
founders. This finding is in keeping with the abnormal Y-chromosome
theory as explained by Luke et al. (2009). A study by Arikawa et al.
(2016) demonstrated an impact on the SSR in patients undergoing IVF
treatment in the presence of abnormal spermmotility when compared
to those with normal sperm motility (SSR 104.08 versus 114.59, OR
0.91 95% CI 0.82–1.00) (Arikawa et al., 2016).
Human ejaculation is known to contain an equal ratio of X:Y sper-
matozoa (Graffelman et al., 1999; Viloria et al., 2005; Bowman et al.,
1998). Studies looking at sperm swim-up techniques for sperm selec-
tion have suggested a potential impact of the method on sex selection
(Jiang et al., 2016). However, other studies assessing this have not
reported a significant difference in the ratio of X and Y bearing
spermatozoa when using a modified swim-up procedure (Yan et al.,
2006). It is therefore, unclear if the hypothesis that the reduction in
DNA within a Y-chromosome is likely to play a role in sex selection
during natural conception or standard IVF techniques (Cui, 1997).
A small study (Fedder et al., 2007) assessing the gender ratio fol-
lowing ICSI using sperm obtained from testicular, epididymal biopsies
or ejaculation found a SSR of 94 males per 100 female births, 81 males
per 100 female births and 101males per 100 female births, respectively.
Fedder et al. (2007) also reported an SSR of 106 males per 100 female
births with conventional IVF treatment. These results allude to the
possibility of a reduced fertilization rate in the presence of clear male
factor subfertility (Fedder et al., 2007).
Limitations
The interpretation of the analysis is largely dependent on the reporting
and documentation of the clinical data, despite that the number of
cycles and live births analysed for each arm was powered to produce a
statistically significant result. Furthermore, a previous theory of the SSR
being influenced by the patient population cannot be further expanded
upon because of the inability to link multiple cycles to individual
patients.
Clinical practices and success rates have significantly changed since
the inception of the HFEA database in 1991. Thus, inclusion of data
from this time frame may impact the interpretation of the SSR. This has
been accounted for by the large number of cycles included within the
analysis, reducing the noise when analysed for statistical significance.
Furthermore, a sub-analysis for the main treatment type and stage
of embryo transfer for cycles undertaken between 2006–2016 has
confirmed that the trends in SSR described have been maintained
(Supplementary Table SI).
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Conclusion
A number of variables have been demonstrated to influence the SSR,
with a male predominance seen with conventional insemination tech-
niques in IVF treatment cycles and blastocyst stage embryo transfers.
The overall SSR with ART when combining IVF and ICSI treatment
cycles is 104.0 males per 100 female births. The SSR with natural
conception ranges between 103 and 110 males per 100 female births,
representative of the data from the ONS who quote an SSR of 105.3
males per 100 female births for all births within England and Wales for
the same study duration (albeit acknowledging that this birth ratio does
include births following ART, which account for a small proportion of
the total number of births). Thus, in this study ART has been shown
to clearly influence the natural gender equilibrium, with an increased
number of male births following IVF treatment cycles and a decrease
following ICSI treatment cycles. While the clinical relevance of this
impact is still unknown, one has to bear in mind the overall impact
of each method of fertilization on the alteration of the SSR and the
potential route by which each intervention alters the SSR either in
favour of male or female births.While the number of IVF to ICSI cycles
currently being performed appears to balance the overall increase and
decrease seen in the SSR, an all-ICSI policy, however, may tip the
balance towards a reduction in overall male births and thus affect the
gender equilibrium of pregnancies conceived through ART.
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